Pralatrexate-impurities | Pharmaffiliates

Pralatrexate and its Impurities

Pralatrexate is used to treat a certain type of cancer known as Peripheral T-Cell Lymphoma. It is an anti-cancer therapy.Reference standards of Pralatrexate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 13 results for Pralatrexate Impurities
PA 16 2620000

Pralatrexate - API Standards

Pralatrexate


  • Catalogue No.:PA 16 2620000

  • CAS :

    146464-95-1

  • Molecular Formula : C23H23N7O5

  • Molecular Weight : 477.48

PA 16 2621000

4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic Acid

4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic Acid


  • Catalogue No.:PA 16 2621000

  • CAS :

    146464-93-9

  • Molecular Formula : C18H16N6O2

  • Molecular Weight : 348.37

PA 16 2621001

10-Propargyl-10-deazaminopterin Diethyl Ester

10-Propargyl-10-deazaminopterin Diethyl Ester


  • Catalogue No.:PA 16 2621001

  • CAS :

    146464-94-0

  • Molecular Formula : C27H31N7O5

  • Molecular Weight : 533.59

PA 16 2621002

Diethyl D-Glutamate Hydrochloride

Diethyl D-Glutamate Hydrochloride


  • Catalogue No.:PA 16 2621002

  • CAS :

    1001-19-0

  • Molecular Formula : C9H18ClNO4

  • Molecular Weight : 239.7

PA 16 2621003

(4-(2-(2,4-Diaminopteridin-7-yl)ethyl)benzoyl)glutamic Acid

(4-(2-(2,4-Diaminopteridin-7-yl)ethyl)benzoyl)glutamic Acid


  • Catalogue No.:PA 16 2621003

  • CAS :

    2058054-07-0

  • Molecular Formula : C20H21N7O5

  • Molecular Weight : 439.43

PA 16 2621004

(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic Acid

(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic Acid


  • Catalogue No.:PA 16 2621004

  • CAS :

    1548618-61-6

  • Molecular Formula : C23H22N6O6

  • Molecular Weight : 478.47

PA 16 2621005

10-Carbomethoxy Pralatrexate

10-Carbomethoxy Pralatrexate


  • Catalogue No.:PA 16 2621005

  • CAS :

    NA

  • Molecular Formula : C25H25N7O7

  • Molecular Weight : 535.52

PA 16 2621006

(4-(2-((2,4-Diaminopteridin-6-yl)methyl)-1-(2-methoxyethoxy)-1-oxopent-4-yn-2-yl)benzoyl)-L-glutamic Acid

(4-(2-((2,4-Diaminopteridin-6-yl)methyl)-1-(2-methoxyethoxy)-1-oxopent-4-yn-2-yl)benzoyl)-L-glutamic Acid


  • Catalogue No.:PA 16 2621006

  • CAS :

    NA

  • Molecular Formula : C27H29N7O8

  • Molecular Weight : 579.57

PA 16 2621007

(4S)-4-(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic Acid

(4S)-4-(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic Acid


  • Catalogue No.:PA 16 2621007

  • CAS :

    NA

  • Molecular Formula : C24H25N7O5

  • Molecular Weight : 491.51

PA 16 2621008

(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic acid

(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic acid


  • Catalogue No.:PA 16 2621008

  • CAS :

    1548618-62-7

  • Molecular Formula : C24H25N7O5

  • Molecular Weight : 491.51

PA 16 2621009

Dimethyl (4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamate

Dimethyl (4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamate


  • Catalogue No.:PA 16 2621009

  • CAS :

    374777-77-2

  • Molecular Formula : C25H27N7O5

  • Molecular Weight : 505.54

PA 16 2621010

(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-D-glutamic Acid

(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-D-glutamic Acid


  • Catalogue No.:PA 16 2621010

  • CAS :

    1451250-74-0

  • Molecular Formula : C23H23N7O5

  • Molecular Weight : 477.48

PA 16 2621011

R-Pralatrexate

R-Pralatrexate


  • Catalogue No.:PA 16 2621011

  • CAS :

    1320211-70-8

  • Molecular Formula : C23H23N7O5

  • Molecular Weight : 477.48